STAGE DEV MAY, 2013

Plans A-E

Plans A-E

CCHP employer group plans enable you to provide quality, affordable health care for your employees. Quality health care coverage keeps your employees healthy and more productive. It also helps attract and retain valuable employees. They can enjoy peace of mind by providing a way to keep their families healthy.

tab01 plans-a-e

2017 Benefit Highlights

Plan Benefit Highlights

Summary of Benefits and Coverage (SBC)

Evidence of Coverage (EOC)

CCHP Provider Directory - HMO (English and Chinese)

To start an online Provider Search, click here

Pharmacy Directory (English)

Formulary

* There are four tiers in the drug formulary. Tiers include the types of drugs that are covered. Please refer to your Evidence of Coverage and Disclosure Form for details.

Tier Definition
1 1) Most generic drugs and low cost preferred brands.
2 1) Non-preferred generic drugs or;
2) Preferred brand name drugs or;
3) Recommended by the plan's pharmaceutical and therapeutics (P&T) committee based on drug safety, efficacy and cost.
3
 
1) Non-preferred brand name drugs or;
2) Recommended by P&T committee based on drug safety, efficacy and cost or;
3) Generally have a preferred and often less costly therapeutic alternative at a lower tier.
4

 

1) Food and Drug Administration (FDA) or drug manufacturer limits distribution to specialty pharmacies or;
2) Self administration requires training, clinical monitoring or;
3) Drug was manufactured using biotechnology or;
4) Plan cost (net of rebates) is >$600.

 

tab02 plans-a-e

2016 Benefit Highlights

Plan Benefit Highlights

Summary of Benefits and Coverage (SBC)

Evidence of Coverage (EOC)

Provider Directory (English and Chinese)

Pharmacy Directory (English)

Formulary

* There are four tiers in the drug formulary. Tiers include the types of drugs that are covered. Please refer to your Evidence of Coverage and Disclosure Form for details.

Tier Definition
1 1) Most generic drugs and low cost preferred brands.
2 1) Non-preferred generic drugs or;
2) Preferred brand name drugs or;
3) Recommended by the plan's pharmaceutical and therapeutics (P&T) committee based on drug safety, efficacy and cost.
3
 
1) Non-preferred brand name drugs or;
2) Recommended by P&T committee based on drug safety, efficacy and cost or;
3) Generally have a preferred and often less costly therapeutic alternative at a lower tier.
4

 

1) Food and Drug Administration (FDA) or drug manufacturer limits distribution to specialty pharmacies or;
2) Self administration requires training, clinical monitoring or;
3) Drug was manufactured using biotechnology or;
4) Plan cost (net of rebates) is >$600.

 

 

STAGE DEV MAY, 2013